Drug
Cr011 Vcmmae
Cr011 Vcmmae: highest development phase Phase 1/2, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CR011-vcMMAE NCT00704158 | Phase 1/2 | Breast Cancer |
Latest
No recent events.
Follow Cr011 Vcmmae on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.